The blood group typing market size has grown rapidly in recent years. It will grow from $3.46 billion in 2025 to $3.93 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to expansion of blood transfusion procedures, growth in hospital laboratory services, rising surgical volumes, increased blood donation screening, standardization of transfusion protocols.
The blood group typing market size is expected to see rapid growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing adoption of molecular typing techniques, rising demand for rapid compatibility testing, expansion of automated laboratory workflows, growing investments in transfusion safety systems, technological advances in blood group diagnostics. Major trends in the forecast period include increasing adoption of automated blood typing systems, rising demand for high-throughput testing platforms, growing use of molecular blood group typing, expansion of advanced reagent and kit solutions, enhanced focus on transfusion safety.
The blood group typing market experienced growth during the historic period, driven by a notable increase in the number of blood donations and transfusions. Various non-profit organizations, government entities, and agencies have been actively promoting the significance of blood donations through awareness campaigns. This surge in blood donations has led to an augmented demand for blood group typing, enabling donors to ascertain their blood type. For instance, in February 2024, according to CDC (Centers for Disease Control and Prevention), U.S-based government agency reported that, in 2024, there are approximately 7 million blood donors and more than 14 million units of blood transfused annually in the United States. The upswing in blood donations and transfusions has thus been a significant factor propelling the growth of the blood typing market.
Leading companies in the blood group typing market are focusing on developing innovative products using advanced technologies like next-generation sequencing (NGS) to improve the accuracy and efficiency of blood typing processes. NGS allows for a detailed analysis of genetic variations in blood group antigens, providing more precise and comprehensive blood group typing. For example, in April 2023, Metropolis Healthcare Limited, an India-based healthcare company, introduced the NextGen HLA Typing Test. This test leverages NGS technology to enhance the precision of human leukocyte antigen (HLA) typing for organ transplants, improving compatibility assessments between donors and recipients, which is essential for successful transplant outcomes.
In March 2023, Werfen, S.A., a Spain-based company operating in blood group typing, hemostasis, and transfusion, completed the acquisition of Immucor Inc. for approximately US$2 billion. This strategic move expanded Werfen's position as a reference business in the specialized diagnostics market and broadened its diagnostic solutions for hospitals and clinical laboratories. The acquisition integrated Immucor Inc., a U.S.-based company specializing in blood group typing, into Werfen's portfolio, strengthening the company's range by adding Transfusion and Transplant product lines to its existing Hemostasis, Acute Care, and Autoimmunity business lines. The acquisition is a testament to Werfen's commitment to enhancing its capabilities and offerings in the blood gas and electrolyte analyzer market.
Major companies operating in the blood group typing market are Grifols S.A., Bio-Rad Laboratories Inc., Immucor Inc., Ortho-Clinical Diagnostics Inc., Quotient Limited, AXO Science SAS, Agena Bioscience Inc., Merck KGaA, Beckman Coulter Inc., DIAGAST SAS, Thermo Fisher Scientific Inc., One Lambda Inc., Tulip Diagnostics (P) Ltd., Guangzhou Wondfo Biotech Co. Ltd., DiaSorin S.p.A., Grifols Diagnostic Solutions Inc., Hemo bioscience Inc., Medion Diagnostics GmbH, ZenTech S.A., BioMedomics Inc., Lifespan Diagnostics LLC.
North America was the largest region in the blood group typing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the blood group typing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood group typing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood group typing market by increasing costs of imported reagents, diagnostic kits, analyzers, and laboratory automation components. Hospital laboratories and blood banks in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces pricing pressure on export-oriented diagnostic manufacturing. These tariffs are raising testing costs and procurement budgets. However, they are also encouraging local reagent manufacturing, regional kit production, and domestic laboratory equipment assembly.
The blood group typing market research report is one of a series of new reports that provides blood group typing market statistics, including blood group typing industry global market size, regional shares, competitors with a blood group typing market share, detailed blood group typing market segments, market trends and opportunities, and any further data you may need to thrive in the blood group typing industry. This blood group typing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood group typing is a method employed to determine an individual's blood type, facilitating safe blood donation or transfusion.
Key types of blood group typing include antibody screening, cross-matching tests, ABO tests, antigen typing, and human leukocyte antigen (HLA) typing. Antibody screening tests are conducted in clinical laboratories or blood banks to identify unexpected antibodies, such as alloantibodies, in the serum related to non-ABO blood group antigens. Cross-matching tests are integral to blood compatibility testing before transfusions. HLA typing, a genetic test, identifies variations in immune system proteins, commonly used for matching patients and donors in bone marrow or cord blood transplants. ABO tests categorize blood types into A, B, AB, or O. Antigen tests, utilizing immunoassays, detect specific viral antigens and are employed in the diagnosis of respiratory pathogens like influenza viruses. Products used for blood group typing include instruments, reagents, and kits, employing techniques such as serology tests and molecular tests. Blood group typing finds application in hospital-based laboratories, independent laboratories, and blood banks.
The blood group typing market consists of sale of serology reagents, gel systems, lateral flow rapid technology, and blood group genotyping products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood group typing market size is expected to see rapid growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing adoption of molecular typing techniques, rising demand for rapid compatibility testing, expansion of automated laboratory workflows, growing investments in transfusion safety systems, technological advances in blood group diagnostics. Major trends in the forecast period include increasing adoption of automated blood typing systems, rising demand for high-throughput testing platforms, growing use of molecular blood group typing, expansion of advanced reagent and kit solutions, enhanced focus on transfusion safety.
The blood group typing market experienced growth during the historic period, driven by a notable increase in the number of blood donations and transfusions. Various non-profit organizations, government entities, and agencies have been actively promoting the significance of blood donations through awareness campaigns. This surge in blood donations has led to an augmented demand for blood group typing, enabling donors to ascertain their blood type. For instance, in February 2024, according to CDC (Centers for Disease Control and Prevention), U.S-based government agency reported that, in 2024, there are approximately 7 million blood donors and more than 14 million units of blood transfused annually in the United States. The upswing in blood donations and transfusions has thus been a significant factor propelling the growth of the blood typing market.
Leading companies in the blood group typing market are focusing on developing innovative products using advanced technologies like next-generation sequencing (NGS) to improve the accuracy and efficiency of blood typing processes. NGS allows for a detailed analysis of genetic variations in blood group antigens, providing more precise and comprehensive blood group typing. For example, in April 2023, Metropolis Healthcare Limited, an India-based healthcare company, introduced the NextGen HLA Typing Test. This test leverages NGS technology to enhance the precision of human leukocyte antigen (HLA) typing for organ transplants, improving compatibility assessments between donors and recipients, which is essential for successful transplant outcomes.
In March 2023, Werfen, S.A., a Spain-based company operating in blood group typing, hemostasis, and transfusion, completed the acquisition of Immucor Inc. for approximately US$2 billion. This strategic move expanded Werfen's position as a reference business in the specialized diagnostics market and broadened its diagnostic solutions for hospitals and clinical laboratories. The acquisition integrated Immucor Inc., a U.S.-based company specializing in blood group typing, into Werfen's portfolio, strengthening the company's range by adding Transfusion and Transplant product lines to its existing Hemostasis, Acute Care, and Autoimmunity business lines. The acquisition is a testament to Werfen's commitment to enhancing its capabilities and offerings in the blood gas and electrolyte analyzer market.
Major companies operating in the blood group typing market are Grifols S.A., Bio-Rad Laboratories Inc., Immucor Inc., Ortho-Clinical Diagnostics Inc., Quotient Limited, AXO Science SAS, Agena Bioscience Inc., Merck KGaA, Beckman Coulter Inc., DIAGAST SAS, Thermo Fisher Scientific Inc., One Lambda Inc., Tulip Diagnostics (P) Ltd., Guangzhou Wondfo Biotech Co. Ltd., DiaSorin S.p.A., Grifols Diagnostic Solutions Inc., Hemo bioscience Inc., Medion Diagnostics GmbH, ZenTech S.A., BioMedomics Inc., Lifespan Diagnostics LLC.
North America was the largest region in the blood group typing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the blood group typing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood group typing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood group typing market by increasing costs of imported reagents, diagnostic kits, analyzers, and laboratory automation components. Hospital laboratories and blood banks in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces pricing pressure on export-oriented diagnostic manufacturing. These tariffs are raising testing costs and procurement budgets. However, they are also encouraging local reagent manufacturing, regional kit production, and domestic laboratory equipment assembly.
The blood group typing market research report is one of a series of new reports that provides blood group typing market statistics, including blood group typing industry global market size, regional shares, competitors with a blood group typing market share, detailed blood group typing market segments, market trends and opportunities, and any further data you may need to thrive in the blood group typing industry. This blood group typing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood group typing is a method employed to determine an individual's blood type, facilitating safe blood donation or transfusion.
Key types of blood group typing include antibody screening, cross-matching tests, ABO tests, antigen typing, and human leukocyte antigen (HLA) typing. Antibody screening tests are conducted in clinical laboratories or blood banks to identify unexpected antibodies, such as alloantibodies, in the serum related to non-ABO blood group antigens. Cross-matching tests are integral to blood compatibility testing before transfusions. HLA typing, a genetic test, identifies variations in immune system proteins, commonly used for matching patients and donors in bone marrow or cord blood transplants. ABO tests categorize blood types into A, B, AB, or O. Antigen tests, utilizing immunoassays, detect specific viral antigens and are employed in the diagnosis of respiratory pathogens like influenza viruses. Products used for blood group typing include instruments, reagents, and kits, employing techniques such as serology tests and molecular tests. Blood group typing finds application in hospital-based laboratories, independent laboratories, and blood banks.
The blood group typing market consists of sale of serology reagents, gel systems, lateral flow rapid technology, and blood group genotyping products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Group Typing Market Characteristics
3. Blood Group Typing Market Supply Chain Analysis
4. Global Blood Group Typing Market Trends and Strategies
5. Blood Group Typing Market Analysis of End Use Industries
7. Global Blood Group Typing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Group Typing Total Addressable Market (TAM) Analysis for the Market
9. Blood Group Typing Market Segmentation
10. Blood Group Typing Market Regional and Country Analysis
11. Asia-Pacific Blood Group Typing Market
12. China Blood Group Typing Market
13. India Blood Group Typing Market
14. Japan Blood Group Typing Market
15. Australia Blood Group Typing Market
16. Indonesia Blood Group Typing Market
17. South Korea Blood Group Typing Market
18. Taiwan Blood Group Typing Market
19. South East Asia Blood Group Typing Market
20. Western Europe Blood Group Typing Market
21. UK Blood Group Typing Market
22. Germany Blood Group Typing Market
23. France Blood Group Typing Market
24. Italy Blood Group Typing Market
25. Spain Blood Group Typing Market
26. Eastern Europe Blood Group Typing Market
27. Russia Blood Group Typing Market
28. North America Blood Group Typing Market
29. USA Blood Group Typing Market
30. Canada Blood Group Typing Market
31. South America Blood Group Typing Market
32. Brazil Blood Group Typing Market
33. Middle East Blood Group Typing Market
34. Africa Blood Group Typing Market
36. Blood Group Typing Market Competitive Landscape and Company Profiles
37. Blood Group Typing Market Other Major and Innovative Companies
40. Blood Group Typing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Group Typing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood group typing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood group typing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood group typing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Test Type: Antibody Screening; Cross-Matching Tests; ABO Tests; Antigen Typing; HLA Typing2) By Product: Instruments; Reagents And Kits
3) By Techniques: Serology Tests; Molecular Tests
4) By End User: Hospital Based Laboratories; Independent Laboratories And Blood Banks
Subsegments:
1) By Antibody Screening: Indirect Coombs Test; Enzyme-Linked Immunosorbent Assay (ELISA)2) By Cross-Matching Tests: Major Crossmatch; Minor Crossmatch; Electronic Crossmatch
3) By ABO Tests: Forward Typing; Reverse Typing
4) By Antigen Typing: Rh Factor Typing; Kell Typing; Other Blood Group Antigen Typings
5) By HLA Typing: Serological Methods; Molecular Methods (PCR-based)
Companies Mentioned: Grifols S.A.; Bio-Rad Laboratories Inc.; Immucor Inc.; Ortho-Clinical Diagnostics Inc.; Quotient Limited; AXO Science SAS; Agena Bioscience Inc.; Merck KGaA; Beckman Coulter Inc.; DIAGAST SAS; Thermo Fisher Scientific Inc.; One Lambda Inc.; Tulip Diagnostics (P) Ltd.; Guangzhou Wondfo Biotech Co. Ltd.; DiaSorin S.p.A.; Grifols Diagnostic Solutions Inc.; Hemo bioscience Inc.; Medion Diagnostics GmbH; ZenTech S.A.; BioMedomics Inc.; Lifespan Diagnostics LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Group Typing market report include:- Grifols S.A.
- Bio-Rad Laboratories Inc.
- Immucor Inc.
- Ortho-Clinical Diagnostics Inc.
- Quotient Limited
- AXO Science SAS
- Agena Bioscience Inc.
- Merck KGaA
- Beckman Coulter Inc.
- DIAGAST SAS
- Thermo Fisher Scientific Inc.
- One Lambda Inc.
- Tulip Diagnostics (P) Ltd.
- Guangzhou Wondfo Biotech Co. Ltd.
- DiaSorin S.p.A.
- Grifols Diagnostic Solutions Inc.
- Hemo bioscience Inc.
- Medion Diagnostics GmbH
- ZenTech S.A.
- BioMedomics Inc.
- Lifespan Diagnostics LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.93 Billion |
| Forecasted Market Value ( USD | $ 6.46 Billion |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
